← 返回

二硫死亡:帕金森病和癌症的新靶点

英文原题:Disulfidptosis: A New Target for Parkinson's Disease and Cancer.

查看英文原题

Disulfidptosis: A New Target for Parkinson's Disease and Cancer.

PubMed 2024/09/12(内容时间) Curr Issues Mol Biol Q2 · IF 4.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

近期研究揭示了帕金森病(PD)与癌症这两个看似不同的疾病类别之间存在引人注目的联系。二硫死亡作为一种新型的程序性细胞死亡形式,已引起关注,它参与多种病理状态,包括神经退行性疾病和癌症。二硫死亡涉及细胞内氧化还原稳态的失调,导致二硫键积累和随后的细胞死亡。这激发了我们的兴趣,去探索可能参与神经退行性疾病与肿瘤发生之间关系的共同分子机制和遗传因素。使用 Gene4PD 数据库检索 PD 差异表达基因(DEGs),分析差异表达二硫死亡相关基因(DEDRGs)的生物学功能,使用 GEO 数据库分析 DEDRGs 的 ROC,并通过 MPTP 诱导的 PD 小鼠模型在体内验证 DEDRGs 的表达。

然后,利用多组学分析数据,对 30 多种癌症的 9000 多份样本中的 DEDRGs 进行了全面而系统的表征。在 PD 中,我们共获得四个 DEDRGs,包括 ACTB、ACTN4、INF2 和 MYL6。富集的生物学功能包括调控 NF-κB 信号通路、线粒体功能、凋亡和肿瘤坏死因子,并且这些基因在不同脑区中富集。在 MPTP 诱导的 PD 小鼠模型中,ACTB 的表达降低,而 ACTN4、INF2 和 MYL6 的表达升高。在泛癌中,ACTB、ACTN4 和 MYL6 在 GBMLGG、LGG、MESO 和 LAML 中的高表达预后较差,INF2 在 LIHC、LUAD、UVM、HNSC、GBM、LAML 和 KIPAN 中的高表达预后较差。

我们的研究表明,这些基因在泛癌患者的巨噬细胞、NK 细胞、中性粒细胞、嗜酸性粒细胞、CD8 T 细胞、T 细胞、T 辅助细胞、B 细胞、树突状细胞和肥大细胞中浸润更高。大多数替换突变是 G-to-A 转换和 C-to-T 转换。

我们还发现 miR-4298、miR-296-3p、miR-150-3p、miR-493-5p 和 miR-6742-5p 在癌症和 PD 中发挥重要作用。环磷酰胺和炔雌醇可能是未来研究中受 DEDRGs 影响的潜在药物。

本研究发现 ACTB、ACTN4、INF2 和 MYL6 与 PD 和泛癌密切相关,可作为神经退行性疾病和癌症诊断、预后及治疗生物标志物的候选基因。

展开英文摘要原文

Recent studies have uncovered intriguing connections between Parkinson's disease (PD) and cancer, two seemingly distinct disease categories. Disulfidptosis has garnered attention as a novel form of regulated cell death that is implicated in various pathological conditions, including neurodegenerative disorders and cancer. Disulfidptosis involves the dysregulation of intracellular redox homeostasis, leading to the accumulation of disulfide bonds and subsequent cell demise. This has sparked our interest in exploring common molecular mechanisms and genetic factors that may be involved in the relationship between neurodegenerative diseases and tumorigenesis. The Gene4PD database was used to retrieve PD differentially expressed genes (DEGs), the biological functions of differential expression disulfidptosis-related genes (DEDRGs) were analyzed, the ROCs of DEDRGs were analyzed using the GEO database, and the expression of DEDRGs was verified by an MPTP-induced PD mouse model in vivo.

Then, the DEDRGs in more than 9000 samples of more than 30 cancers were comprehensively and systematically characterized by using multi-omics analysis data. In PD, we obtained a total of four DEDRGs, including ACTB , ACTN4 , INF2 , and MYL6 . The enriched biological functions include the regulation of the NF-κB signaling pathway, mitochondrial function, apoptosis, and tumor necrosis factor, and these genes are rich in different brain regions.

In the MPTP-induced PD mouse model, the expression of ACTB was decreased, while the expression of ACTN4, INF2, and MYL6 was increased. In pan-cancer, the high expression of ACTB, ACTN4, and MYL6 in GBMLGG, LGG, MESO, and LAML had a poor prognosis, and the high expression of INF2 in LIHC, LUAD, UVM, HNSC, GBM, LAML, and KIPAN had a poor prognosis.

Our study showed that these genes were more highly infiltrated in Macrophages, NK cells, Neutrophils, Eosinophils, CD8 T cells, T cells, T helper cells, B cells, dendritic cells, and mast cells in pan-cancer patients. Most substitution mutations were G-to-A transitions and C-to-T transitions.

We also found that miR-4298, miR-296-3p, miR-150-3p, miR-493-5p, and miR-6742-5p play important roles in cancer and PD. Cyclophosphamide and ethinyl estradiol may be potential drugs affected by DEDRGs for future research.

This study found that ACTB , ACTN4 , INF2 , and MYL6 are closely related to PD and pan-cancer and can be used as candidate genes for the diagnosis, prognosis, and therapeutic biomarkers of neurodegenerative diseases and cancers.

论文信息

作者
Liu T、Kong X、Wei J
单位
Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.China
期刊
Current issues in molecular biology2024 Sep 12
原文标识
PubMed 39329952 · DOI 10.3390/cimb46090600